Advocacy intelligence hub — real-time data for patient organizations
NYU Langone Health
Mycobutin: FDA approved
Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infections.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance2
Mycobutin
Adria Laboratories, Inc.
Rifabutin
Pfizer
Mycobutin
(Rifabutin)Orphan drugAdria Laboratories, Inc.
Rifamycin Antimycobacterial [EPC]
Mechanism of Action Rifabutin inhibits DNA-dependent RNA polymerase in susceptible strains of Escherichia coli and Bacillus subtilis but not in mammal...
View all OBSOLETE: Mycobacterium xenopi infection specialists →